[Fertility preservation for transwomen].

Place de la préservation de la fertilité dans le parcours de transition des femmes transgenres.
Autoconservation de spermatozoïdes Femmes transgenres Fertility preservation MtF Préservation de la fertilité Sperm cryopreservation Transidentity Transidentité Transwomen

Journal

Gynecologie, obstetrique, fertilite & senologie
ISSN: 2468-7189
Titre abrégé: Gynecol Obstet Fertil Senol
Pays: France
ID NLM: 101693805

Informations de publication

Date de publication:
06 2021
Historique:
received: 16 06 2020
pubmed: 13 1 2021
medline: 25 11 2021
entrez: 12 1 2021
Statut: ppublish

Résumé

The evolution of medical care for transgender people currently makes it possible to propose fertility preservation. Fertility preservation should be initiated before the start of hormonal treatments and/or surgical procedures. The "reproductive" aspect and the desire for parenthood among transgender people have long been ignored. However, these aspects are important to consider and fertility preservation should be discussed before the start of the physical transition. The aim of this review is to assess the literature on fertility preservation for transgender women ("male to female"). Many uncertainties remain regarding the impact of hormonal treatments on the reproductive functions of transgender women and their reversibility. However, the significant increase in the number of recently published articles is evidence of the improvement in the conditions of access to these procedures for women starting a transition process. Nevertheless, there are still a number of barriers that can prevent or delay this process.

Identifiants

pubmed: 33434749
pii: S2468-7189(21)00008-8
doi: 10.1016/j.gofs.2021.01.007
pii:
doi:

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

547-552

Informations de copyright

Copyright © 2021. Published by Elsevier Masson SAS.

Auteurs

E Benaloun (E)

Service de biologie de la reproduction CECOS, AP-HP, hôpital Tenon, Paris, France.

N Sermondade (N)

Service de biologie de la reproduction-CECOS, AP-HP, hôpital Tenon, Sorbonne université, Saint-Antoine Research centre, Inserm équipe lipodystrophies génétiques et acquises, Paris, France.

E Moreau (E)

Service de biologie de la reproduction CECOS, AP-HP, hôpital Tenon, Paris, France.

N Chabbert-Buffet (N)

Service de gynécologie-obstétrique et médecine de la reproduction, AP-HP, hôpital Tenon, Paris, France.

S Cristofari (S)

Service de chirurugie plastique reconstructrice et esthétique, AP-HP, hôpital Tenon, Sorbonne université, Paris, France.

N Johnson (N)

Service de gynécologie-obstétrique et médecine de la reproduction, AP-HP, hôpital Tenon, Paris, France.

R Lévy (R)

Service de biologie de la reproduction-CECOS, AP-HP, hôpital Tenon, Sorbonne université, Saint-Antoine Research centre, Inserm équipe lipodystrophies génétiques et acquises, Paris, France.

C Dupont (C)

Service de biologie de la reproduction-CECOS, AP-HP, hôpital Tenon, Sorbonne université, Saint-Antoine Research centre, Inserm équipe lipodystrophies génétiques et acquises, Paris, France. Electronic address: charlotte.dupont@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH